Purchase Order 75D30125P20356
Award Date
12/7/24
Potential Completion Date
12/6/25
Potential Value
$145K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for maintenance, repair, and support services on two Illumina NextSeq 1000 instruments. The $239,670.64 contract has a base period of 12 months and three 12-month option periods, with services to be performed in Atlanta, Georgia. The award was made under simplified acquisition procedures, and there were no set-aside...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The contract is for the maintenance, repair, and support of Illumina's NovaSeq 6000 and MiSeq sequencing instruments over a 2-year period, with a ceiling value of $139,336.76. This contract does not have a set-aside designation. Illumina has previously received prime federal contracts and...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents, for the maintenance of laboratory equipment. The contract has a ceiling value of $14,329.00 and a performance period ending on July 20, 2024. The award does not utilize any set-aside provisions. Illumina has a history of providing sequencing systems, reagents, and services to support...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $12,944.40, is for the maintenance of Illumina equipment. It does not have a set-aside designation. Illumina has a history of providing a range of genomic sequencing systems, reagents, and support services to various federal agencies, including the...
The Centers for Disease Control and Prevention (CDC) awarded a $245,828.32 firm-fixed-price purchase order to Illumina, Inc. for annual maintenance services on Illumina instruments, including the NextSeq1000 and MiSeq, for a 5-year period from September 9, 2024 through September 8, 2029. The services include health checks, preventive maintenance, and repairs as needed. This purchase order was competed with no set-aside designation. Illumina is a manufacturer of sequencing and array-based...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $223,532.40, is for the maintenance and services of Illumina sequencing instruments. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a maintenance agreement with a total ceiling value of $75,716.00 and a period of performance through June 10, 2021. The contract does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies such as the...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for a laboratory maintenance agreement covering the agency's Illumina MiSeq, MiSeqDX and NextSeq 550 next-generation sequencing systems. The $578,796.68 contract provides annual on-site preventative maintenance and 24-48 hour on-site repair services for the covered equipment, as Illumina is the original manufacturer and its factory-trained personnel have the required...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $83,870.68, is for preventative maintenance services on Illumina's MiSeq instruments. The period of performance runs from the award date of July 10, 2018, through June 30, 2023. This award does not utilize a set-aside. Illumina has a history of...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the purchase of DNA prep library and sequencing kits compatible with Illumina's MiSeq, MiniSeq, and NextSeq instruments. The CDC is the sole source for these Illumina products, as Illumina is the only manufacturer and does not have any authorized resellers in the United States. The total ceiling value of the purchase order is $248,576.11, with a period of performance...